Difference between revisions of "Help:Assembly standard 25"
Line 149: | Line 149: | ||
− | + | ==References== | |
*[[Freiburg07/NgoMIV_MEBinfo| NgoMIV NEB information]]<BR> | *[[Freiburg07/NgoMIV_MEBinfo| NgoMIV NEB information]]<BR> | ||
*Nishikubo T, Nakagawa N, Kuramitsu S, Masui R "Improved heterologous gene expression in Escherichia coli by optimization of the AT-content of codons immediately downstream of the initiation codon." J Biotechnol. 2005 Dec 6;120(4):341-6<BR> | *Nishikubo T, Nakagawa N, Kuramitsu S, Masui R "Improved heterologous gene expression in Escherichia coli by optimization of the AT-content of codons immediately downstream of the initiation codon." J Biotechnol. 2005 Dec 6;120(4):341-6<BR> | ||
*Pfleger BF, Fawzi NJ, Keasling JD "Optimization of DsRed production in Escherichia coli: effect of ribosome binding site sequestration on translation efficiency." Biotechnol Bioeng. 2005 Dec 5;92(5):553-8<BR> | *Pfleger BF, Fawzi NJ, Keasling JD "Optimization of DsRed production in Escherichia coli: effect of ribosome binding site sequestration on translation efficiency." Biotechnol Bioeng. 2005 Dec 5;92(5):553-8<BR> | ||
*Varshavsky A "The N-end rule: functions, mysteries, uses." Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12142-9 [http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=8901547&ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum pubmed]<BR> | *Varshavsky A "The N-end rule: functions, mysteries, uses." Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12142-9 [http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=8901547&ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum pubmed]<BR> |
Revision as of 04:13, 2 February 2009
Contents
Introduction
The generalized BioBrick prefix and suffix with its easy cloning strategy is an excellent and universal way to combine various parts, e.g. promoter region, gene of interest, terminator etc. However, it is not well-suited for in-frame assembly of protein domains due to the 8 bp SpeI/XbaI scar.
Suffix of the first part (part in gray, PstI, NotI, SpeI):
...ACtactagtagcggccgctgcag
combined with Prefix of the second part (EcoRI, NotI, XbaI,part in gray):
gaattccgcggccgcttctagagCA...
results after an SpeI/Xba combination in:
...ACtactagagCA...
encoding the amino acids Tyr (codon: <codon>tac</codon>), STOP (codon: tag
) and Ser or Arg (codon agn
).
Consequently, protein domains cannot be designed as separate BioBrick parts and assembled together. The Freiburg assembly standard was developed to address this shortcoming while retaining compatibility with the original BioBrick version. The Freiburg standard extends the original BioBrick standard with two additional compatible restriction sites to allow for the modular assembly of protein fusion parts. For the Freiburg standard, appropriate enzymes were chosen carefully to include ensure coding for amino acids which are compatible with flexible linkers as well as with the N-end rule for protein stability.
Proposal
We propose to extend the standard BioBrick suffix and prefix with two
additional compatible restriction sites. The frame of the standard suffix and
prefix remains the same resulting in complete compatibility with any previously
designed parts. We chose the restriction sites NgoMVI and AgeI as they code for
the amino acids Ala-Gly or Thr-Gly, respectively, which are compatible with
flexible linkers commonly used in fusion proteins and also compatible with the
N-end rule for protein stabiliy. Consequently, we name these parts
FusionParts. A combination of two such FusionParts creates an
AgeI/NgoMIV scar coding for Thr-Gly, which can easily be integrated in any
linker sequence. Furthermore, the NgoMIV site (coding for Ala-Gly) after the
start Methionin of the standard BioBrick suffix adheres completely to the N-end
rule. For proteins, which are sensitive to amino acid addition at the
N-terminus, we also devised an N-Part with a suffix that lacks the NgoMIV site.</p>
The following list summarizes the most important factors of the BioBrick 3.0 design
Strategy for iGEM BioBrick 3.0 parts for mix-and-match construction of fusion proteins
developed by the iGEM Team Freiburg
- Both parts, the FusionPart and the N-part are fully compatible with all standard iGEM parts as they have the BioBricks prefix for coding sequences and the standard BioBrick suffix.
- Both parts have two additional enzymes, NgoMIV and AgeI, which have compatible cohesive ends and enable in-frame fusion of protein parts with the linker sequence TG (no stop codons).
- The only difference of the N-part and FusionPart is the additional NgoMIV site in the FusionPart.
- The FusionPart is the universal part for fusion proteins, and it can be a stand-alone protein part as it has a start codon after the XbaI site (BioBrick prefix for coding sequence), with two additional amino acids (A, G) encoded before the start of the protein.
- The N-part is designed to be the start of a fusion protein or a stand-alone protein part,, in which the N-terminus is sensitive to any amino acid addition, to be cloned via XbaI/PstI to any iGEM RBS expression part.
- The FusionPart can be fused to the N-part by digesting the N-part with AgeI/SpeI and the FusionPart with NgoMIV/SpeI.
- Any number of FusionParts can be combined and optionally fused to the N-part.
- nnnnnn is a place holder for the coding sequence of the respective part.
Prefix
BioBrick 3.0 FusionPrefix (EcoRI, NotI, XbaI, NgoMIV, part in gray;
original BioBrick prefix for coding sequences underlined):gaattccgcggccgcttctagatggccggcCA...
BioBrick 3.0 N-partPrefix is identical to the BioBrick prefix for coding
sequences (EcoRI, NotI,
XbaI, part in gray):gaattccgcggccgcttctagATG...
Suffix
BioBrick 3.0 FusionSuffix (part in gray, AgeI, SpeI, NotI,
PstI; original BioBrick suffix underlined):...ACaccggttaatactagtagcggccgctgcag
Combining the respective prefix and suffix generates the following FusionPart and N-part:
FusionPart
NaeI BsrFI
SfcI
ApoI
BsrFI | BsaWI
MspA1I|
EcoRI NotI
XbaI NgoMIV |
AgeI
SpeI NotI
||PstI
| |
| | |
| |
| || |
GAATTCgcggccgctTCTAGAtgGCCGGCnnnnnnACCGGTtaatACTAGTagcggccgCTGCAG
1 ---------+---------+---------+---------+---------+---------+----- 65
CTTAAGcgccggcgaAGATCTacCGGCCGnnnnnnTGGCCAattaTGATCAtcgccggcGACGTC
c I R G R F * M
A G ? ? T G * Y * *
R P L Q -
N-part
BsrFI
SfcI
ApoI
BsaWI
MspA1I|
EcoRI NotI
XbaI
AgeI
SpeI NotI
||PstI
| |
| |
| | || |
GAATTCgcggccgctTCTAGAtgnnnnnnACCGGTtaatACTAGTagcggccgCTGCAG
1 ---------+---------+---------+---------+---------+--------- 59
CTTAAGcgccggcgaAGATCTacnnnnnnTGGCCAattaTGATCAtcgccggcGACGTC
c I R G R F * M
? ? T G * Y * *
R P L Q -
References
- NgoMIV NEB information
- Nishikubo T, Nakagawa N, Kuramitsu S, Masui R "Improved heterologous gene expression in Escherichia coli by optimization of the AT-content of codons immediately downstream of the initiation codon." J Biotechnol. 2005 Dec 6;120(4):341-6
- Pfleger BF, Fawzi NJ, Keasling JD "Optimization of DsRed production in Escherichia coli: effect of ribosome binding site sequestration on translation efficiency." Biotechnol Bioeng. 2005 Dec 5;92(5):553-8
- Varshavsky A "The N-end rule: functions, mysteries, uses." Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12142-9 [http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=8901547&ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum pubmed]